[Individual variations in the frequency of chromosome aberrations following exposure to chemical mutagens. II. Interindividual variation in the frequency of chromosome aberrations in the presence of different mutagen concentrations]. 1976

K I Iakovenko, and T O Tarusina, and N P Kuleshov

The object of this investigation was the distribution of human periferal blood cultured obtained from different donors with respect to their sensitivity to different concentrations of thiophosphamide (10, 20 and 30 mcg/ml for 1 hour). Two test characteristics were studied, "the proportion of aberrant metaphases" and "the number of chromosome breaks per 100 cells". It is shown that the distribution of individuals does not depend on the mutagen concentration, being normal in all the series of experiments. The same results were obtained when two different statistical methods were used, viz. the method of four moments and the chi-square test. Since the former method is less labour-consuming, the authors recommend it for fitting the normal distribution in cytogenetic investigations. The variances of the test-characteristics studies ("percent aberrant metaphases" and "total number of breaks per 100 cells") increased with the increase of the mean values. Therefore, before the analysis of variance and the regression analysis the cytogenetic data should be preliminary transformed for the purpose of stabilization of variances.

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002875 Chromosomes In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Chromosome
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013852 Thiotepa A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed). Thio-Tepa,Thiophosphamide,Triethylenethiophosphoramide,AI3-24916,Girostan,NSC-6396,Tespa,Tespamin,Tris(1-aziridinyl)phosphine Sulfide,AI3 24916,AI324916,NSC 6396,NSC6396,Thio Tepa
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic

Related Publications

K I Iakovenko, and T O Tarusina, and N P Kuleshov
September 1989, Biulleten' eksperimental'noi biologii i meditsiny,
K I Iakovenko, and T O Tarusina, and N P Kuleshov
October 1971, Environmental research,
K I Iakovenko, and T O Tarusina, and N P Kuleshov
January 1978, Biulleten' eksperimental'noi biologii i meditsiny,
K I Iakovenko, and T O Tarusina, and N P Kuleshov
December 1971, Mutation research,
K I Iakovenko, and T O Tarusina, and N P Kuleshov
January 1983, Mutation research,
K I Iakovenko, and T O Tarusina, and N P Kuleshov
January 1984, IARC scientific publications,
K I Iakovenko, and T O Tarusina, and N P Kuleshov
December 1977, Mutation research,
K I Iakovenko, and T O Tarusina, and N P Kuleshov
November 1972, Mutation research,
K I Iakovenko, and T O Tarusina, and N P Kuleshov
January 1974, TSitologiia i genetika,
Copied contents to your clipboard!